Table 1 Antifungal activities of the title compounds 5–9 at 50 mg/L
From: Synthesis and antifungal activities of novel nicotinamide derivatives containing 1,3,4-oxadiazole
Compound | Inhibition ratea(%) | ||
|---|---|---|---|
| Â | G. zeae | F. oxysporum | C.mandshurica |
5 | 17.9 ± 1.6 | 10.3 ± 0.9 | 15.5 ± 0.7 |
6 | 33.2 ± 1.7 | 21.3 ± 1.1 | 30.3 ± 1.9 |
7a | 19.0 ± 2.9 | 55.2 ± 0.6 | 53.1 ± 1.3 |
7b | 46.4 ± 1.3 | 51.1 ± 1.0 | 49.9 ± 1.1 |
7c | 39.6 ± 1.3 | 31.9 ± 1.4 | 44.9 ± 0.7 |
7d | 27.9 ± 0.2 | 12.5 ± 1.7 | 17.3 ± 1.0 |
8 | 53.0 ± 2.4 | 58.9 ± 4.3 | 52.8 ± 1.3 |
9a | 43.2 ± 0.6 | 63.2 ± 0.9 | 59.8 ± 1.4 |
9b | 58.3 ± 2.7 | 53.3 ± 3.9 | 54.5 ± 1.2 |
9c | 45.6 ± 1.8 | 47.6 ± 1.0 | 49.3 ± 1.1 |
9d | 35.4 ± 1.9 | 17.2 ± 0.3 | 34.3 ± 0.9 |
Hymexazolb | 55.54 ± 3.9 | 56.12 ± 2.1 | 49.61 ± 3.2 |
Carbendazolb | 100 ± 3.74 | 100 ± 4.9 | 100 ± 5.23 |